Peg-interferon a-2a (40KD) with or without ribavirin in the treatment of naive patients with recurrent hepatitis C after liver transplantation

被引：0
|
作者：
Petrolati, A
Lionetti, R
Lenci, I
Di Paolo, D
Donato, F
Merli, M
Angeli, P
Burra, P
Strazzabosco, M
di Bergamo, O
Tisone, G
Angelico, M
机构：
[1] Univ Roma Tor Vergata, Hepatol Unit, Rome, Italy
[2] Univ Milan, Milan, Italy
[3] Univ Roma La Sapienza, Rome, Italy
[4] Univ Padua, Rome, Italy
[5] Osped Riuniti Bergamo, Rome, Italy
[6] Univ Roma Tor Vergata, Transplant Unit, Rome, Italy
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：482A / 482A
页数：1
相关论文
共 50 条
  • [21] PEG-IFN alfa-2a (40KD) (Pegasys) plus amantadine (AMA) or ribavirin (RBV) in naive patients with chronic hepatitis C
    Ideo, G
    Giuseppe, S
    Attili, A
    Chirianni, A
    Craxi, A
    Di Perri, G
    Picciotto, A
    Rizzetto, M
    Ruggiero, G
    Suter, F
    Sarracino, M
    [J]. HEPATOLOGY, 2002, 36 (04) : 570A - 570A
  • [22] The effect of statins on PEG-interferon/ribavirin treatment for chronic hepatitis C
    Yen, Roy D.
    Prabhu, Anoop
    Mahl, Thomas
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S217 - S217
  • [23] HBV RNA IN SERUM IS A PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING TREATMENT WITH PEG-INTERFERON ALPHA-2a (40KD)
    van Boemmel, F.
    van Boemmel, A.
    He, H.
    Wat, C.
    Deichsel, D.
    Berg, T.
    Boehm, S.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S442 - S443
  • [24] Treatment of recurrent hepatitis C after liver transplantation with Interferon alfa 2b and Ribavirin
    Zamboni, F
    Franchello, A
    Lavezzo, B
    Strignano, P
    Schellino, M
    Rizzetto, M
    Salizzoni, M
    [J]. TRANSPLANTATION, 2000, 69 (08) : S265 - S265
  • [25] Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation
    Lodato, F.
    Berardi, S.
    Gramenzi, A.
    Mazzella, G.
    Lenzi, M.
    Morelli, M. C.
    Tame, M. R.
    Piscaglia, F.
    Andreone, P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (04) : 450 - 457
  • [26] Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation
    Dinges, S.
    Morard, I.
    Heim, M.
    Dufour, J.-F.
    Mullhaupt, B.
    Giostra, E.
    Clavien, P. -A.
    Mentha, G.
    Negro, F.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (01) : 33 - 39
  • [27] Prediction of early virologic response to treatment with 40KD pegylated (PEG)-interferon (IFN) alfa2a/ribavirin in patients with chronic hepatitis C (genotype 1)
    Ferenci, P
    Jessner, W
    Hackl, F
    Gschwantier, M
    Brunner, H
    Hellmich, B
    Laferi, H
    Stauber, R
    Hubmann, R
    Datz, C
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [28] PEG-IFN alfa-2a (40KD) (PEGASYS®) plus amantadine (AMA) or ribavirin (RBV) in naive patients with chronic hepatitis C (CHC).
    Ideo, G
    Antonucci, G
    Attili, AF
    Babudieri, S
    Chirianni, A
    Craxì, A
    Di Perri, G
    Francavilla, A
    Mangia, A
    Picciotto, A
    Rizzetto, M
    Ruggiero, G
    Suter, F
    Tripi, S
    Sarracino, M
    [J]. HEPATOLOGY, 2003, 38 (04) : 728A - 728A
  • [29] PEG-IFN alfa-2a (40KD) (Pegasys) plus amantadine (AMA) or ribavirin (RBV) in naive patients with chronic hepatitis C (CHC)
    Ideo, G
    Attili, A
    Ruggiero, G
    Craxi, A
    Di Perri, G
    Mangia, A
    Picciotto, A
    Rizzetto, M
    Suter, F
    Sarracino, M
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 146 - 146
  • [30] Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha
    Fischer, L
    Sterneck, M
    Valentin-Gamazo, C
    Feucht, HH
    Malagó, M
    Broelsch, CE
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 494 - 495
12345